Best Stocks: Repros Therapeutics Inc. (NASDAQ:RPRX), XBiotech, Inc. (NASDAQ:XBIT), Google Inc (NASDAQ:GOOG), Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Merck & Co. Inc. (NYSE:MRK)

Repros Therapeutics Inc. (NASDAQ:RPRX) belongs to Healthcare sector. Its weekly performance is 9.38%. On last trading day company shares ended up $7.81. Repros Therapeutics Inc. (NASDAQ:RPRX) distance from 50-day simple moving average (SMA50) is 5.82%. Repros Therapeutics Inc. (NASDAQ:RPRX) is scheduled to be reviewed by the FDA’s Division of Bone, Reproductive and Urologic Products on Nov 3.

XBiotech, Inc. (NASDAQ:XBIT) shares moved down -6.03% in last trading session and ended the day at $15.27. Its return on assets is -90.40%. On July 07, XBiotech, Inc. (NASDAQ:XBIT) announced publication of clinical results from an open label pilot study for its antibody therapy for treatment of Type 2 diabetes. The results are now available online as an “Article in Press” in the Journal of Diabetes and its Complications. The findings point towards a groundbreaking therapy for Type 2 diabetes by treating the disease rather than its symptoms. The Company has developed a True Human monoclonal antibody therapy derived from an individual with natural immunity to the body’s own inflammatory process that can disrupt pancreas function and limit insulin action.

On 14 July, Google Inc (NASDAQ:GOOG) belongs to Technology sector. Its weekly performance is 6.87%. On last trading day company shares ended up $561.10. Google Inc (NASDAQ:GOOG) distance from 50-day simple moving average (SMA50) is 5.33%. Google Inc (NASDAQ:GOOG) is putting its own spin on beacon technology, releasing the open-source, cross-platform beacon format Eddystone.

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) belongs to Healthcare sector. Its weekly performance is 3.01%. On last trading day company shares ended up $7.88. Inovio Pharmaceuticals, Inc. (NASDAQ:INO) distance from 50-day simple moving average (SMA50) is -5.30%. Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced that its Chief Executive Officer, Dr. J. Joseph Kim, has been selected by The Aspen Institute to join its Health Innovators Fellowship. Dr. Kim, who co-founded Inovio, will work with a group of 20 healthcare leaders challenged to generate new solutions to improve healthcare treatments, access and delivery. He also joins 2,000 other Aspen Fellows from 48 countries who comprise the Aspen Global Leadership Network.

Merck & Co. Inc. (NYSE:MRK) belongs to Healthcare sector. Its net profit margin is 27.00% and weekly performance is 0.34%. On last trading day company shares ended up $58.19. Merck & Co. Inc. (NYSE:MRK) distance from 50-day simple moving average (SMA50) is -1.01%. On July 07, Allergan plc (NYSE: AGN) and Merck (NYSE: MRK) announced that they have entered into an agreement under which Allergan will acquire the exclusive worldwide rights to Merck’s investigational small molecule oral calcitonin gene-related peptide (CGRP) receptor antagonists, which are being developed for the treatment and prevention of migraine, subject to expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR).

Leave a Reply

Your email address will not be published. Required fields are marked *